Citrate Articles

Articles

  • [Use of citrate in patients with nephrolithiasis].

    Citrate is a tricarboxylic acid and an intermediate metabolite of Krebs cycle. It contributes to oxidative metabolism of both kidney and liver. Alkaline sodium or potassium salts have the potential to increase alkaline reserve.

    Published September 25, 2017
  • Effectiveness of Treatment Modalities on Kidney Stone Recurrence.

    Nephrolithiasis is highly prevalent across all demographic groups in the Western world and beyond, and its incidence rates are rising. In addition to the morbidity of the acute event, stone disease often becomes a lifelong problem that requires preventative therapy to diminish ongoing morbidity.

    Published August 26, 2017
  • Epidemiology of Kidney Stones.

    In the past two decades, major breakthroughs that improve our understanding of the pathophysiology and therapy of kidney stones (KS) have been lacking. The disease continues to be challenging for patients, physicians, and healthcare systems alike.

    Published February 13, 2023
  • Three-channel ion chromatograph for improved metabolic evaluation of urolithiasis.

    Urolithiasis is a multi-etiological disease resulting from a combination of environmental and genetic factors. One of the most challenging aspects of this disease is its high recurrence rate. For most patients, an in-depth metabolic evaluation may reveal the presence of urinary stones.

    Published November 15, 2021
  • Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer.

    Magnetic resonance imaging (MRI) can portray spatial variations in tumor heterogeneity, architecture, and its microenvironment in a non-destructive way. The objective of this study was to assess the relationship between MRI parameters measured on patients in vivo, individual metabolites measured in prostatectomy tissue ex vivo, and quantitative histopathology.

    Published July 8, 2016
  • Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease.

    Kidney stone disease seems to be associated with an increased risk of incident cardiovascular outcomes; the aim of this study is to identify differences in 24-h urine excretory profiles and stone composition among stone formers with and without cardiovascular disease (CVD).

    Published August 2, 2021